Citigroup Reiterates Neutral Rating on Health Catalyst, Inc. (HCAT)
Citigroup reiterated its Neutral rating on Health Catalyst, Inc. (NASDAQ:HCAT) on August 11, 2026.
Read moreReal-time context
Upgrades, downgrades, initiations, and price-target changes.
Citigroup reiterated its Neutral rating on Health Catalyst, Inc. (NASDAQ:HCAT) on August 11, 2026.
Read moreCitigroup analysts downgraded Accendra Health, Inc. (NYSE:ACH) from Buy to Neutral on August 11, 2026.
Read moreRosenblatt reiterated its Buy rating on Viant Technology Inc. (NASDAQ:DSP) on August 11, 2026.
Read moreCitizens reiterated its Market Outperform rating on Viant Technology Inc. (NASDAQ:DSP) on August 11, 2026.
Read moreDA Davidson reiterated its Buy rating on Viant Technology Inc. (NASDAQ:DSP) on August 11, 2026.
Read morePiper Sandler reiterated its Overweight rating on Perspective Therapeutics, Inc. (AMEX:CATX) on August 11, 2026.
Read moreDA Davidson reiterated its Buy rating on CPI Card Group Inc. (NASDAQ:PMTS) on August 11, 2026.
Read moreGuggenheim reiterated its Buy rating on Tenax Therapeutics, Inc. (NASDAQ:TENX) on August 11, 2026.
Read moreBTIG reiterated its Buy rating on AppLovin Corporation (NASDAQ:APP) on August 12, 2026.
Read moreOppenheimer analysts upgraded Intuitive Surgical, Inc. (NASDAQ:ISRG) from Perform to Outperform on August 12, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Alpha Tau Medical Ltd.
Read moreMorgan Stanley reiterated its Equal-Weight rating on TaskUs, Inc. Class A Common Stock (NASDAQ:TASK) on August 11, 2026.
Read moreNeedham reiterated its Buy rating on Upwork Inc. (NASDAQ:UPWK) on August 11, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on Upwork Inc. (NASDAQ:UPWK) on August 11, 2026.
Read moreScotiabank reiterated its Sector Perform rating on Upwork Inc. (NASDAQ:UPWK) on August 11, 2026.
Read moreWells Fargo reiterated its Overweight rating on Rh (NYSE:RH) on August 11, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Apple Hospitality REIT, Inc. (NYSE:APLE) on August 11, 2026.
Read moreNeedham reiterated its Buy rating on Hims & Hers Health, Inc. (NYSE:HIMS) on August 11, 2026.
Read moreCitigroup reiterated its Neutral rating on Hims & Hers Health, Inc. (NYSE:HIMS) on August 11, 2026.
Read moreDeutsche Bank reiterated its Hold rating on Hims & Hers Health, Inc. (NYSE:HIMS) on August 11, 2026.
Read more